These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 20703256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS, Greene JM, McConnell TS, Willman CL.
    Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422
    [Abstract] [Full Text] [Related]

  • 4. Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients.
    Hovorkova L, Winkowska L, Skorepova J, Krumbholz M, Benesova A, Polivkova V, Alten J, Bardini M, Meyer C, Kim R, Trahair TN, Clappier E, Chiaretti S, Henderson M, Sutton R, Sramkova L, Stary J, Polakova KM, Marschalek R, Metzler M, Cazzaniga G, Cario G, Trka J, Zaliova M, Zuna J.
    Mol Cancer; 2024 Jul 05; 23(1):138. PubMed ID: 38970095
    [Abstract] [Full Text] [Related]

  • 5. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice.
    Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N.
    Blood; 1995 Dec 15; 86(12):4603-11. PubMed ID: 8541551
    [Abstract] [Full Text] [Related]

  • 6. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
    Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA.
    J Exp Med; 1999 May 03; 189(9):1399-412. PubMed ID: 10224280
    [Abstract] [Full Text] [Related]

  • 7. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
    Suh SP, Kee SJ, Lim WH, Song JW, Lee SK, Kim JP, Shin JH, Ryang DW.
    Clin Chem Lab Med; 2000 Sep 03; 38(9):939-44. PubMed ID: 11097354
    [Abstract] [Full Text] [Related]

  • 8. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.
    Burmeister T, Gröger D, Kühn A, Hoelzer D, Thiel E, Reinhardt R.
    DNA Repair (Amst); 2011 Nov 10; 10(11):1131-7. PubMed ID: 21944569
    [Abstract] [Full Text] [Related]

  • 9. BCR-ABL gene variants.
    Melo JV.
    Baillieres Clin Haematol; 1997 Jun 10; 10(2):203-22. PubMed ID: 9376660
    [Abstract] [Full Text] [Related]

  • 10. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.
    Adnan-Awad S, Kim D, Hohtari H, Javarappa KK, Brandstoetter T, Mayer I, Potdar S, Heckman CA, Kytölä S, Porkka K, Doma E, Sexl V, Kankainen M, Mustjoki S.
    Leukemia; 2021 Jul 10; 35(7):1964-1975. PubMed ID: 33168949
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM, Kreisel FH, Zehnbauer BA, Kulkarni S, Hassan A, Frater JL.
    Am J Hematol; 2008 Dec 10; 83(12):901-7. PubMed ID: 18932238
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR.
    Zhang JG, Goldman JM, Cross NC.
    Br J Haematol; 1995 May 10; 90(1):138-46. PubMed ID: 7786776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D, Tabernero MD, Rasillo A, Sayagués JM, Espinosa AB, Chillón MC, Garcia-Sanz R, Gutierrez N, Giralt M, Hagemeijer A, San Miguel JF, Orfao A.
    Leukemia; 2003 Jun 10; 17(6):1124-9. PubMed ID: 12764379
    [Abstract] [Full Text] [Related]

  • 18. Pak1 gene functioned differentially in different BCR-ABL subtypes in leukemiagenesis and treatment response through STAT5 pathway.
    Yuanxin Y, Yanhong Z, Qin Z, Sishi T, Yang D, Yi Z, Minjin W, Juan Z, Xiaojun L, Lanlan W, Binwu Y.
    Leuk Res; 2019 Apr 10; 79():6-16. PubMed ID: 30784762
    [Abstract] [Full Text] [Related]

  • 19. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
    Fujimaki K, Maruta A, Yoshida M, Yamazaki E, Motomura S, Kodama F, Matsuzaki M, Fujisawa S, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2001 Feb 10; 42(2):89-93. PubMed ID: 11280922
    [Abstract] [Full Text] [Related]

  • 20. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells.
    Daubon T, Rochelle T, Bourmeyster N, Génot E.
    Eur J Cell Biol; 2012 Feb 10; 91(11-12):978-87. PubMed ID: 22717125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.